Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV colistin plus nebulized colistin vs IV ampicillin-sulbactam plus nebulized colistin for ventilator-associated pneumonia due to Acinetobacter baumannii
IRCT20120703010178N18Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Mar 2019
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of colistin and ampicillin + sulbactam in ventilator-associated pneumonia (VAP) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Started Mar 2019; status: completed.
02
Drugs
colistinampicillin + sulbactam
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on IRCT20120703010178N18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120703010178N18.